Natural Language Processing (NLP) in Healthcare and Life Sciences

Natural Language Processing (NLP) in Healthcare and Life Sciences

Global Natural Language Processing (NLP) in Healthcare and Life Sciences Market to Reach US$18.0 Billion by 2030

The global market for Natural Language Processing (NLP) in Healthcare and Life Sciences estimated at US$2.6 Billion in the year 2023, is expected to reach US$18.0 Billion by 2030, growing at a CAGR of 31.7% over the analysis period 2023-2030. NLP Solutions, one of the segments analyzed in the report, is expected to record a 29.5% CAGR and reach US$9.8 Billion by the end of the analysis period. Growth in the NLP Services segment is estimated at 34.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$884.4 Million While China is Forecast to Grow at 39.3% CAGR

The Natural Language Processing (NLP) in Healthcare and Life Sciences market in the U.S. is estimated at US$884.4 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2030 trailing a CAGR of 39.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 25.3% and 29.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 29.3% CAGR.

Global Natural Language Processing (NLP) in Healthcare and Life Sciences Market – Key Trends & Drivers Summarized

How Is NLP Transforming Healthcare and Life Sciences?

Natural Language Processing (NLP) is revolutionizing healthcare and life sciences by enabling computers to interpret, analyze, and act on human language. This technology is streamlining clinical workflows, automating documentation, and enhancing patient care by extracting actionable insights from unstructured data, such as medical notes, research articles, and patient feedback. In electronic health records (EHRs), NLP simplifies the retrieval of critical information, reducing the administrative burden on healthcare professionals and allowing them to focus on patient care. Additionally, in life sciences, NLP accelerates drug discovery by analyzing vast volumes of scientific literature and identifying patterns that inform research and development.

NLP is also improving decision-making through predictive analytics, helping healthcare providers identify at-risk patients and intervene proactively. For example, sentiment analysis and patient-reported outcomes are being used to gauge treatment effectiveness and improve clinical trials. The integration of NLP with artificial intelligence (AI) and machine learning (ML) is further enhancing its capabilities, enabling systems to continuously learn and adapt to complex medical language. As the demand for precision medicine grows, NLP is becoming an indispensable tool for personalized healthcare and innovative treatments.

Why Are Stakeholders Investing in NLP for Healthcare and Life Sciences?

The increasing complexity of healthcare data is prompting significant investments in NLP solutions. Healthcare providers and researchers face challenges in processing and interpreting unstructured data, which accounts for a substantial portion of medical records and research findings. NLP bridges this gap by transforming unstructured information into structured data, facilitating efficient analysis and informed decision-making. Pharmaceutical companies are leveraging NLP to optimize clinical trial designs, identify patient cohorts, and streamline regulatory submissions, reducing costs and time-to-market for new drugs.

Patients are also driving the adoption of NLP through their expectations for more personalized and efficient healthcare services. Chatbots and virtual health assistants powered by NLP are improving patient engagement, providing accurate information, and reducing wait times. Moreover, as value-based care models gain traction, NLP is helping healthcare systems analyze outcomes and improve care delivery. These applications underscore the growing importance of NLP in addressing the operational and clinical challenges faced by healthcare and life sciences stakeholders.

How Are Technological Advancements Shaping NLP in Healthcare and Life Sciences?

Advancements in AI and ML are propelling the evolution of NLP in healthcare and life sciences, making it more accurate, scalable, and efficient. Contextual language models, such as GPT and BERT, are enabling NLP systems to understand medical jargon, detect subtle nuances, and provide context-aware insights. Speech recognition technologies are also improving, allowing for seamless transcription of medical dictations and real-time language translation for multilingual patient populations.

The integration of NLP with cloud-based platforms and big data analytics is further expanding its applications. These technologies enable real-time processing of vast data volumes, ensuring timely insights for clinical decision-making and research. Additionally, federated learning and privacy-preserving AI are addressing concerns about data security, ensuring compliance with regulations such as HIPAA and GDPR. These technological advancements are enhancing the adoption of NLP across the healthcare and life sciences sectors, empowering stakeholders to tackle complex challenges with greater efficiency and precision.

What Factors Are Driving Growth in the NLP Market for Healthcare and Life Sciences?

The growth in the Natural Language Processing (NLP) in healthcare and life sciences market is driven by several factors, including the rising volume of unstructured data in medical records, the increasing demand for AI-driven solutions, and the shift towards value-based care. The adoption of advanced technologies, such as contextual language models and cloud computing, is enabling healthcare providers and researchers to unlock valuable insights from data. Consumer behavior trends, such as the growing preference for virtual health assistants and personalized care, are encouraging healthcare systems to invest in NLP-powered solutions.

Additionally, the expansion of clinical research and the need for more efficient drug discovery processes are driving the use of NLP in analyzing scientific literature and streamlining regulatory workflows. Regulatory pressures to maintain accurate documentation and ensure compliance are further promoting the adoption of NLP in healthcare. The growing focus on interoperability and seamless data sharing is also creating opportunities for NLP to bridge gaps across systems. These factors collectively underscore the transformative potential of NLP in healthcare and life sciences, paving the way for improved patient outcomes and operational efficiencies.

SCOPE OF STUDY:

The report analyzes the Natural Language Processing (NLP) in Healthcare and Life Sciences market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Component (NLP Solutions, NLP Services); Deployment (Cloud Deployment, On-Premise Deployment); Technique (Text Classification Technique, Optical Character Recognition Technique, Name Entity Recognition Technique, Sentiment Analysis Technique, Topic Modeling Technique, Other NLP Techniques); End-Use (Healthcare Researchers End-Use, Pharmaceutical & Biotech Companies, Health Insurance & Payer Professionals End-Use, Other End Uses)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Rest of Europe; Asia-Pacific; Latin America; Rest of World.

Select Competitors (Total 63 Featured) -

• Amazon Web Services, Inc.
• Averbis GmbH
• Clinithink Ltd.
• Corti ApS
• Deep 6 AI, Inc.
• Ellipsis Health, Inc.
• Emtelligent
• Enlitic Inc.
• Forsee Medical, Inc.
• Gnani Innovations Pvt. Ltd.
• IBM Corp.
• Inovalon Holdings, Inc.
• IQVIA, Inc.
• ITRex Group
• John Snow Labs, Inc.
• Press Ganey
• Wave Health Technologies

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.